Establishment Labs Holdings Hits New 52-Week High of $86.00

Establishment Labs Holdings, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 86.00 on June 18, 2026. This achievement marks a remarkable increase from its 52-week low of USD 33.35, showcasing a robust performance over the past year with a gain of 74.97%. The company's market capitalization stands at USD 1,644 million, reflecting its position within the small-cap category. Despite being loss-making, Establishment Labs Holdings has demonstrated resilience in a competitive industry, particularly when compared to the S&P 500, which has seen a performance increase of 25.41% during the same period. Key financial metrics indicate a debt-to-equity ratio of 7.90, highlighting the company's leverage, while its return on equity is reported at -216.86%. The price-to-book ratio stands at 69.83, further illustrating the company's valuation in the market. As Establishment Labs Holdings continues to navigate the dynamic landscape of pharmaceuticals and biotechnology, its recent performance underscores its current market position.